Inventor · disambiguated record
Antti Aalto
Also filed as: AALTO ANTTI
4 granted patents·2 pending applications·40 citations·filing 2017–2024
76Inventor score
Files withPROQR THERAPEUTICS II BV6
Top patents by PatentIndex Score
6 records- 0193US11851656B2Chemically modified single-stranded RNA-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2021·Granted Dec 26, 2023·6 cites·40 claims
- 0293US10941402B2Chemically modified single-stranded RNA-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2017·Granted Mar 9, 2021·16 cites·22 claims
- 0391US12203072B2Chemically modified single-stranded rna-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2023·Granted Jan 21, 2025·1 cites·29 claims
- 0491US11274300B2Oligonucleotide complexes for use in RNA editingPROQR THERAPEUTICS II BV·Filed 2018·Granted Mar 15, 2022·17 cites·20 claims
- 0585US2025223593A1Chemically modified single-stranded rna-editing oligonucleotidesPROQR THERAPEUTICS II BV·Filed 2024·Application pending·0 cites
- 0651US2022340900A1Chemically modified oligonucleotides for rna editingPROQR THERAPEUTICS II BV·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Antti Aalto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →